Three shades of an unusual mediastinal tumour.
暂无分享,去创建一个
A. Takano | C. Y. Chow | S. Mantoo | L. S. Punjabi | K. Lim
[1] S. Khader,et al. Thoracic SMARCA4‐deficient undifferentiated tumor with associated granulomatous reaction and response to pembrolizumab , 2023, Diagnostic cytopathology.
[2] N. Rekhtman,et al. Diagnosis of thoracic SMARCA4‐deficient undifferentiated tumor in cytology , 2023, Cancer cytopathology.
[3] S. Sugita,et al. Usefulness of cell block examination for the cytological diagnosis of thoracic SMARCA4‐deficient undifferentiated tumor: A case report , 2023, Diagnostic cytopathology.
[4] A. Thakar,et al. Fine needle aspiration cytology of metastatic SMARCA4‐deficient sinonasal teratocarcinosarcoma: First report in literature , 2023, Diagnostic cytopathology.
[5] M. Bui,et al. Assessing rapid on-site evaluation (ROSE) for adequacy of endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA) compared to a direct-to-cellblock approach as a response to COVID-19 pandemic , 2022, Journal of the American Society of Cytopathology.
[6] A. Nambirajan,et al. Recent updates in thoracic SMARCA4-deficient undifferentiated tumor. , 2021, Seminars in diagnostic pathology.
[7] F. Le Loarer,et al. SWI/SNF-deficient thoraco-pulmonary neoplasms. , 2021, Seminars in diagnostic pathology.
[8] L. Bubendorf,et al. Cytology of SMARCA4-Deficient Thoracic Neoplasms: Comparative Analysis of SMARCA4-Deficient Non-Small Cell Lung Carcinomas and SMARCA4-Deficient Thoracic Sarcomas , 2020, Acta Cytologica.
[9] C. VandenBussche,et al. Review of SMARCA4 (BRG1)-deficient carcinomas following a malignant pleural effusion specimen confounded by reduced claudin-4 expression. , 2020, Journal of the American Society of Cytopathology.
[10] C. Ohbayashi,et al. Cytopathological Features of SMARCA4-Deficient Thoracic Sarcoma: Report of 2 Cases and Review of the Literature , 2020, International journal of surgical pathology.
[11] David R. Jones,et al. SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[12] S. Pambuccian,et al. A BAFfling liver aspirate: Metastatic high grade SMARCA4 deficient undifferentiated gastroesophageal junction carcinoma masquerading as a hematolymphoid malignancy , 2019, Diagnostic cytopathology.
[13] S. Kuwamoto,et al. Cytologic Features of SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Comparison with Other SWI/SNF Complex-Deficient Tumors , 2018, Acta Cytologica.
[14] N. Girard,et al. SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas , 2015, Nature Genetics.